Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.12533 http://scihub22266oqcxt.onion/10.18632/oncotarget.12533 C5356913!5356913!27732962     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncotarget 2017 ; 8 (2): 3711-23 Nephropedia Template TP {{tp|p=27732962|t=2017. Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation |pdf=|usr=}}{{27732962}} gab.com Text Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=27732962 #FOAvip Soluble fibrinogen-like protein 2 (sFGL2) is the soluble form of fibrinogen-like protein 2 belonging to the fibrinogen-related protein superfamily. It is now well characterized that sFGL2 is mainly secreted by regulatory T cell (Treg) populations, and exerts potently immunosuppressive activities. By repressing not only the differentiation and proliferation of T cells but also the maturation of dendritic cells (DCs), sFGL2 acts largely as an immunosuppressant. Moreover, sFGL2 also induces apoptosis of B cells, tubular epithelial cells (TECs), sinusoidal endothelial cells (SECs), and hepatocytes. This mini-review focuses primarily on the recent literature with respect to the signaling mechanism of sFGL2 in immunomodulation, and discusses the clinical implications of sFGL2 in transplantation, hepatitis, autoimmunity, and tumors. Twit Text FOAVip Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=27732962 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27732962 #FOAvip English Wikipedia <ref>{{Cite pmid|27732962}}</ref> Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation #MMPMID27732962 Liu Xg; Liu Y; Chen F Oncotarget 2017[Jan]; 8 (2): 3711-23 PMID27732962show ga Soluble fibrinogen-like protein 2 (sFGL2) is the soluble form of fibrinogen-like protein 2 belonging to the fibrinogen-related protein superfamily. It is now well characterized that sFGL2 is mainly secreted by regulatory T cell (Treg) populations, and exerts potently immunosuppressive activities. By repressing not only the differentiation and proliferation of T cells but also the maturation of dendritic cells (DCs), sFGL2 acts largely as an immunosuppressant. Moreover, sFGL2 also induces apoptosis of B cells, tubular epithelial cells (TECs), sinusoidal endothelial cells (SECs), and hepatocytes. This mini-review focuses primarily on the recent literature with respect to the signaling mechanism of sFGL2 in immunomodulation, and discusses the clinical implications of sFGL2 in transplantation, hepatitis, autoimmunity, and tumors. äSoluble fibrinogen like protein 2 (sFGL2), the novel effector molecule(epmc).pdf DeepDyve Pubget Overpricing